Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc. (2018)
- Docket
- 17-1229
- Decided
- 2018-01-01
- Public Good score
- 70 / 100
- Framers' Intent score
- 75 / 100
Summary
Question: Does an inventor’s sale of an invention to a third party who is obligated to keep the invention confidential qualify as prior art for purposes of determining the patentability of the invention? Conclusion: An inventor’s sale to a third party who is obligated to keep the invention confidential constitutes invalidating prior art. Justice Clarence Thomas authored the opinion for a unanimous (9–0) Court. The patent statute in force immediately before the America Invents Act (AIA) contained an “on-sale bar” which invalidated patents that had been on sale. Applying the presumption that when Congress reenacts the same language, it adopts the earlier judicial construction of the phrase, the Court found that the AIA consequently prohibits patents that had previously been on sale. Therefore, the commercial sale to a third party who is required to keep the invention confidential falls within the on-sale bar of the AIA and invalidates the patent.
Case Brief
Facts
Helsinn Healthcare entered into a confidential licensing agreement with a third party to supply a drug formulation. The agreement required the third party to keep the invention confidential. Helsinn later filed a patent application for the same invention and sought to enforce it against Teva after the patent was issued, despite the prior confidential sale.
Procedural History
The district court granted summary judgment for Teva, finding the prior sale triggered the on-sale bar. The Federal Circuit reversed, holding that a confidential sale did not qualify as prior art. Helsinn appealed, and the Supreme Court granted certiorari.
Issue
Does a sale of an invention to a third party who is obligated to maintain confidentiality constitute prior art that invalidates a subsequent patent under the on-sale bar of the Patent Act?
Holding
Yes. A prior sale to a third party under a confidentiality agreement constitutes prior art that invalidates a subsequent patent under the on-sale bar.
Rule
When Congress reenacts statutory language without material change, it adopts judicial interpretations of that language from prior periods. Therefore, the America Invents Act's reenactment of the pre-AIA on-sale bar language incorporated the Supreme Court's prior interpretation that the bar applies to all sales, including confidential ones.
Reasoning
The Court rejected Helsinn's argument that the AIA altered the meaning of 'on sale.' Congress reenacted the identical pre-AIA language, implying adoption of the established judicial construction. The pre-AIA interpretation held that any public or confidential sale triggering the bar was irrelevant to confidentiality. Congress's failure to amend the language after judicial precedent confirmed that confidential sales remain valid prior art.
Significance
Helsinn clarified that the on-sale bar applies to confidential sales, ending a circuit split and preventing inventors from circumventing the bar through confidentiality agreements. This decision significantly impacts patent prosecution strategy and strengthens the temporal requirements for patentability under U.S. law.
Public Good Analysis
GPT: The decision upholds patent integrity by preventing patents on inventions already commercially exploited (even confidentially), promoting public access to technology. However, it risks discouraging early-stage collaborations and innovation by small entities reliant on confidentiality, potentially hindering broader societal benefits from new inventions. | Claude: This decision strengthens the patent system by clarifying what constitutes 'prior art,' preventing companies from indefinitely delaying patent applications while commercially exploiting inventions. This promotes innovation and competition as it prevents extended monopolies unfairly hindering follow-on inventors and ultimately benefiting consumers through lower prices and increased product availability.
Framers' Intent Analysis
GPT: The ruling aligns with the Founders' constitutional purpose in Article I, Section 8 to 'promote the Progress of Science' by preventing patents on inventions made publicly available through commercial use, consistent with Madison's 1790 Patent Bill rationale that exclusive rights must not shield pre-existing public knowledge. | Claude: The framers, particularly James Madison who deeply understood property rights in *Federalist No. 43*, sought to establish a system that incentivized innovation while preventing indefinite monopolies. By upholding the 'on-sale bar,' the Court aligns with this intent; limiting the period of patent protection encourages broader dissemination of knowledge aligning with principles championed by Enlightenment thinkers like Locke, who emphasized the importance of labor and invention for societal progress.